Meyka Pro banner
Blue Ridge Bankshares, Inc.

Stay Updated with the Latest Blue Ridge Bankshares, Inc. BRBS News in Real Time

Find BRBS news now at Meyka AI. Stay informed with the latest Blue Ridge Bankshares, Inc. stocks updates, including price news, market analysis, and expert insights.

BRBSAMEX
Financial ServicesBanks - Regional
$3.49
$0.03(0.87%)
U.S. Market opens in 16h 36m
Best High ROE Tech Stocks With Strong Growth Potential in 2026
📅 3 hours ago

Best High ROE Tech Stocks With Strong Growth Potential in 2026

Return on Equity (ROE) is one of the first metrics many investors check when assessing technology stocks in 2026. With artificial intelligence, cloud computing, and semiconductor demand driving earnings, companies that generate strong returns from shareholder capital continue to attract attention.  In July 2026, several major tech firms reported solid profits even as they increased…

Read more 12
FTSE 100 Climbs 0.42% as Middle East Ceasefire Eases Market Jitters, DAX Surges 1.3%
📅 4 hours ago

FTSE 100 Climbs 0.42% as Middle East Ceasefire Eases Market Jitters, DAX Surges 1.3%

On July 27, 2026, European stock markets moved higher as easing tensions in the Middle East lifted investor confidence. The FTSE 100 rose 0.42%, while Germany’s DAX gained 1.3% after reports of a ceasefire eased concerns about disruptions to global oil supplies. At the same time, crude prices moved lower, raising hopes that inflation could…

Read more 12
Wall Street Ends Volatile Week Mixed as Oil Retreats, Tariffs Loom July 25
📅 3 days ago

Wall Street Ends Volatile Week Mixed as Oil Retreats, Tariffs Loom July 25

S&P 500 flat, Nasdaq down 0.6% Friday as Brent crude drops 4% to $96, Trump tariffs hit 10-12.5%, and Fed rate hike odds jump to 30% next week.

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24
📅 3 days ago

Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24

Generic Zyrtec recalled nationwide due to contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Check your bottles.

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23
📅 4 days ago

Generic Zyrtec Recalled Over Heartburn Drug Mix-Up, July 23

Generic Zyrtec recalled nationwide for cross-contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Call Rising Pharma at 1-844-874-7464.

Read more 12
Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23
📅 4 days ago

Generic Zyrtec Recalled Over Ranitidine Contamination Risk July 23

Generic Zyrtec cetirizine tablets recalled nationwide due to cross-contamination with ranitidine heartburn drug. Four lot numbers affected, expiring October 2028. No adverse events reported yet.

Read more 12
Indian Stocks Q1 Earnings Watch: IEX, Fractal Analytics, Allied Blenders Lead Today’s Results
📅 4 days ago

Indian Stocks Q1 Earnings Watch: IEX, Fractal Analytics, Allied Blenders Lead Today’s Results

Q1 earnings season hits full stride in India on July 23, 2026. Roughly 60 companies report results today, led by Indian Energy Exchange, Fractal Analytics, and Allied Blenders. Infosys, InterGlobe Aviation, and Cipla headline the broader list. Boards at IEX and Fractal Analytics meet today to approve their unaudited Q1 FY27 numbers, while Allied Blenders…

Read more 12
GOOGL Alphabet Earnings Beat Estimates as Cloud Revenue Soars 82%
📅 4 days ago

GOOGL Alphabet Earnings Beat Estimates as Cloud Revenue Soars 82%

On 22 July 2026, Alphabet (NASDAQ: GOOGL) reported stronger-than-expected second-quarter earnings, helped by exceptional growth in its cloud business. Google Cloud revenue jumped 82% year over year, reflecting continued demand for AI services from enterprise customers. The results also showed steady growth in Google’s advertising business despite increasing competition in AI-powered search. While the earnings…

Read more 12
TSLA Stock in Focus as Tesla Reports Q2 Earnings and Margin Outlook
📅 5 days ago

TSLA Stock in Focus as Tesla Reports Q2 Earnings and Margin Outlook

Tesla (NASDAQ: TSLA) is back in the spotlight as the company gets ready to release its second quarter 2026 earnings on 22 July 2026 after the market closes. The report follows a quarter in which Tesla delivered 480,126 vehicles, raising expectations for solid financial results. Even so, investors are looking well beyond delivery numbers. They…

Read more 12

BRBS News FAQ